SCIENTURE HOLDINGS, INC.
NASDAQ: SCNX (Scienture Holdings, Inc.)
最近更新时间: 14小时之前0.415
0.03 (9.05%)
| 前收盘价格 | 0.380 |
| 收盘价格 | 0.378 |
| 成交量 | 584,702 |
| 平均成交量 (3个月) | 1,501,683 |
| 市值 | 16,841,474 |
| 预期市盈率 (P/E Forward) | 21.83 |
| 价格/销量 (P/S) | 18.64 |
| 股市价格/股市净资产 (P/B) | 0.230 |
| 52周波幅 |
| 营业利益率 (TTM) | -34,814.94% |
| 稀释每股收益 (EPS TTM) | 0.660 |
| 季度收入增长率 (YOY) | -58.70% |
| 总债务/股东权益 (D/E MRQ) | 4.70% |
| 流动比率 (MRQ) | 1.05 |
| 营业现金流 (OCF TTM) | -7.03 M |
| 杠杆自由现金流 (LFCF TTM) | -6.06 M |
| 资产报酬率 (ROA TTM) | -14.99% |
| 股东权益报酬率 (ROE TTM) | -35.92% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Pharmaceutical Retailers (US) | 混合的 | 混合的 |
| Pharmaceutical Retailers (全球的) | 混合的 | 混合的 | |
| 股票 | Scienture Holdings, Inc. | 混合的 | - |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.33 |
|
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders. |
|
| 部门 | Healthcare |
| 行业 | Pharmaceutical Retailers |
| 投资方式 | Small Value |
| 内部持股比例 | 32.59% |
| 机构持股比例 | 1.35% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nova Wealth Management, Inc. | 30 Jun 2026 | 30 |
该时间范围内无数据。
该时间范围内无数据。
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 现金 |
| 25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2024 | 9.50 | 2 | 157.03 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合